Inventor · disambiguated record
Michael John Munchhof
Also filed as: MUNCHHOF MICHAEL J · MUNCHHOF MICHAEL JOHN · MUNCHHOF Michael
57 granted patents·42 pending applications·1,242 citations·filing 2000–2023
99Inventor score
Top patents by PatentIndex Score
99 records- 0199US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0299US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0398US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 0498US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 0598US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 0698US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 0797US9365555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jun 14, 2016·37 cites·18 claims
- 0897US6627754B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2000·Granted Sep 30, 2003·103 cites·4 claims
- 0996US9388173B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 12, 2016·32 cites·23 claims
- 1096US9266836B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 23, 2016·35 cites·28 claims
- 1196US9221794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 29, 2015·40 cites·17 claims
- 1296US7091208B2Pyrrolo[2,3-D]pyrimidine compoundsPFIZER·Filed 2005·Granted Aug 15, 2006·34 cites·22 claims
- 1396US6492383B1Thienopyrimidine and thienopyridine derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Dec 10, 2002·163 cites·25 claims
- 1495US9777008B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Oct 3, 2017·16 cites·22 claims
- 1595US9765068B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Sep 19, 2017·14 cites·27 claims
- 1695US9732072B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Aug 15, 2017·16 cites·19 claims
- 1795US9611257B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Apr 4, 2017·22 cites·16 claims
- 1895USRE41783EPyrrolo[2,3-D]pyrimidine compoundsPFIZER·Filed 2009·Granted Sep 28, 2010·25 cites·4 claims
- 1995US6962993B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2003·Granted Nov 8, 2005·68 cites·20 claims
- 2094US10391089B2PRMT5 inhibitors and uses therofEPIZYME INC·Filed 2017·Granted Aug 27, 2019·5 cites·19 claims
- 2194US10307413B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jun 4, 2019·5 cites·39 claims
- 2294US7601727B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2007·Granted Oct 13, 2009·17 cites·12 claims
- 2394US7199123B2Pyrazine compounds as transforming growth factor (TGF) compoundsPFIZER·Filed 2004·Granted Apr 3, 2007·59 cites·18 claims
- 2494US7192963B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2005·Granted Mar 20, 2007·23 cites·48 claims
- 2593US10150758B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Dec 11, 2018·9 cites·7 claims
- 2693US9908887B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 6, 2018·14 cites·18 claims
- 2793US9745291B2PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2013·Granted Aug 29, 2017·14 cites·13 claims
- 2893US7265221B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2006·Granted Sep 4, 2007·15 cites·18 claims
- 2993US6956041B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2003·Granted Oct 18, 2005·37 cites·5 claims
- 3092US6696567B2Pyrrolo[2,3-d]pyrimidine compoundsPFIZER·Filed 2001·Granted Feb 24, 2004·35 cites·1 claims
- 3189US8431597B2Benzimidazole derivativesMUNCHHOF MICHAEL J·Filed 2012·Granted Apr 30, 2013·17 cites·1 claims
- 3289US7301023B2Chiral salt resolutionPFIZER·Filed 2002·Granted Nov 27, 2007·31 cites·1 claims
- 3388US7151110B2Pyrazole compounds as transforming growth factor (TGF) inhibitorsPFIZER PROD INC·Filed 2005·Granted Dec 19, 2006·9 cites·3 claims
- 3487US7842699B2Pyrrolo[2,3-D]pyrimidine compoundsPFIZER·Filed 2009·Granted Nov 30, 2010·5 cites·18 claims
- 3586US10980794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Granted Apr 20, 2021·1 cites·20 claims
- 3686US8148401B2Benzimidazole derivativesMUNCHHOF MICHAEL J·Filed 2008·Granted Apr 3, 2012·10 cites·17 claims
- 3786US7030125B2Isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2003·Granted Apr 18, 2006·24 cites·5 claims
- 3885US7638537B2Pyrazole compounds as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2006·Granted Dec 29, 2009·5 cites·3 claims
- 3984US11697647B2RET kinase inhibitorsLILLY CO ELI·Filed 2021·Granted Jul 11, 2023·1 cites·25 claims
- 4084US7417041B2Imidazopyrimidines as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2004·Granted Aug 26, 2008·18 cites·6 claims
- 4181US10266526B2Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancerEPIZYME INC·Filed 2015·Granted Apr 23, 2019·3 cites·17 claims
- 4281US7635702B2Imidazole compounds as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2006·Granted Dec 22, 2009·4 cites·8 claims
- 4381US7432370B2Chiral salt resolutionPFIZER·Filed 2004·Granted Oct 7, 2008·19 cites·11 claims
- 4481US6958354B2Pyrazole compounds as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2003·Granted Oct 25, 2005·10 cites·3 claims
- 4579US7053095B2Triazole compounds as transforming growth factor (TGF) inhibitorsPFIZER·Filed 2003·Granted May 30, 2006·11 cites·5 claims
- 4678US10577363B2Substituted piperidine compoundsEPIZYME INC·Filed 2015·Granted Mar 3, 2020·2 cites·19 claims
- 4778US7718645B2Substituted bicyclolactam compoundsPFIZER·Filed 2009·Granted May 18, 2010·2 cites·27 claims
- 4877US10118918B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Nov 6, 2018·2 cites·23 claims
- 4977US7153872B2Imidazole compounds as transforming growth factor (TGF) inhibitorsPFIZER PROD INC·Filed 2003·Granted Dec 26, 2006·9 cites·5 claims
- 5077US2021308121A1Prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 99 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →